Meet our Practicioners

Our Team

Dr. Perloff – Director

Dr. Perloff received his undergraduate degree and Doctor of Medicine from the University of Miami in Miami, Florida. He earned numerous awards and honors including the James McKnight award, the McGraw Hill book award, the John M. Marsh Prize, being inducted into the Alpha Omega Alpha medical honorary society, and graduating Summa Cum Laude. He subsequently completed 3 years of internal medicine training and 3 years of invasive cardiology training at Jackson Memorial Hospital in Miami, Florida. He has served the community of Broward County in the private practice of cardiology since 1997.

  • He is board certified in Cardiology and is a fellow of both the American College of Cardiology and the American College of Physicians.
  • He is currently President of the Florida chapter of the American College of Cardiology and has been active on their Board of Directors for many years.
  • He was Chair of the Department of Medicine at Broward Health Medical Center 2018-2020 and Medical Director of Cardiology at Florida Medical Center 2017-2019.
  • He was president of the Broward County Medical Association 2016-2017 and continues to be active on both the Board of Directors and Board of Trustees of the BCMA.
  • Dr. Perloff has been certified to treat Worker’s Compensation patients since the beginning of his practice in 1997 and is involved in all aspects of high-quality, evidence-based, compassionate care for the Worker’s Compensation patient. He serves as a treating physician, performing record reviews and independent medical evaluations. He also is honored to serve as an expert medical advisor for the courts on Worker’s Compensation issues.
  • He is passionate about medical education and teaching. Dr. Perloff is a Clinical Associate Professor at NOVA/Southeastern College of Osteopathic Medicine and an Assistant Professor at the Florida International University College of Medicine. He has been actively teaching residents and medical students at Broward Health Medical Center for over 20 years. He has won numerous awards for this, including Attending of the Year (twice), Most Valuable Physician Award at Broward Health Medical Center, Outstanding Attending Physician Award, and the American College of Physicians – Florida Chapter “Community-Based Teacher” award.
  • He has proudly served on the Orange Theory Fitness Medical Advisory Board for many years.
  • His practice is centrally located in Fort Lauderdale, Florida, where he specializes in general, preventive, and invasive cardiology.

Laurie Siegel – APRN

Yaniret Carmenate – APRN

Raquel – Practice Manager

Giovanna – Medical Assistant

Erica – Office Coordinator

Jessica – Office Coordinator

Volunteer Experience

Dr. Perloff is passionate about providing care for underserved individuals. He has participated in numerous medical missions to the Caribbean. He has brought technologically advanced equipment and his diagnostic skills to aid in the high-quality diagnosis and treatment of the medically needy.

Publications

  • Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus (AleCardio Trial) A. Michael Lincoff, et. al. JAMA April 16, 2014 Vol. 311;15:1515 – 1525
  • Apixaban versus Warfarin in Patients with Atrial Fibrillation. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J. N Engl J Med 2011 Aug 27;: – 10
  • Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial. Insull, Ghali, et al. Mayo Clinic Proceedings May 2007;82(5):543-550
  • Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR* Trial). Jones, Davidson, et al. American Journal of Cardiology 2003; 92:152-160.
  • Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (SPIRE Study). Ridker, Revkin, et al. N Engl J Med 2017; 376:1527-1539

Professional Affiliations

client
client
client
client
client
client